Skip to content

Adherence in neurogeriatric patients

Adherence in neurogeriatric patients - NeuroGerAd

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00016774
Enrollment
1000
Registered
2019-02-19
Start date
2019-02-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focused on main diagnosis/disorders: cerebrovascular diseases, movement disorders, epilepsy, neuromuscular disorders, peripheral neurological disorders. G20 G21 G23 G63 G70 G72 G81 G35 G37 G03 G04 G09 G40 G43 G44 G45 G46 I63 I61 I69 G47 G62 G64 G12 G11

Interventions

Group 1: Observational study: Patients aged 60 years and older with underlying neurological disorders are questioned during their stay at the Department of Neurology by means of a questionnaire: Adher

Sponsors

Universitätsklinikum Jena
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 60 years with a neurological disease

Exclusion criteria

Exclusion criteria: severe dementia, psychosis, delirium, inability to complete questionnaires

Design outcomes

Primary

MeasureTime frame
The primary endpoint is non-adherence in neurogeriatric patients derived from the Stendal Adherence with Medication Score (SAMS). Also disease-specific predictors of non-adherence, taking into account personal, environmental and procedural factors will be determined.

Secondary

MeasureTime frame
Outcome follow-up surveys non-adherence, mortality and health-related quality of life in neurogeriatric patients at 12 months.

Countries

Germany

Contacts

Public ContactTino Prell

Universitätsklinikum Jena Klinik für Neurologie

tino.prell@med.uni-jena.de03641 9323411

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 2, 2026